Muscular Dystrophy Care guides

Topic library · Muscular Dystrophy Guides

Muscular dystrophy: the medicine worked, and the services never caught up

An Australian study of 356 males with Duchenne muscular dystrophy, published in 2025, found median survival rising from 18.2 years for those born before 1970 to 24.0 years for those born in the 1990s. Corticosteroids, cardiac medication and ventilation did that. The authors’ main recommendation was not about drugs: it was that Australia needs transitional and adult services, because the people the medicine saved are now adults in a system designed on the assumption they would not be here. That is the spine of this library. It also covers the other thing that gets missed: muscular dystrophy is more than thirty conditions, most of them adult-onset, and in several of them the thing that shortens life is a heart problem in somebody who is still walking. The cardiac and respiratory surveillance thresholds are set out here as actual numbers, because in adult care nobody books them unless you ask. Written by a registered NDIS provider. Figures are cited to their sources, and we flag the places where the Australian evidence does not exist.

40,000+Australians with muscular dystrophy and similar rare conditions

1 in 5,076Male live births, Duchenne incidence in NSW and the ACT

18.2 → 24.0Median Duchenne survival in years, born pre-1970 vs 1990s

1.8 → 4.8Years from parents’ first concern to diagnosis

Starting points

Which type you have decides almost everything

Muscular dystrophy is more than thirty genetically distinct conditions, not one disease. These five guides cover the group, the types that dominate public attention, and the ones that dominate the actual population.

Guide · 14 min readWhat Is Muscular Dystrophy? An Australian GuideMore than 40,000 Australians, more than thirty conditions, and onset from birth to sixty. What distinguishes the types, why the heart and diaphragm matter more than the legs, and the one test to ask for.

Guide · 15 min readDuchenne Muscular Dystrophy: An Australian GuideAustralian parents raise concerns at 1.8 years and diagnosis comes at 4.8. One cheap blood test closes that gap. Plus the surveillance schedule, and what the steroids actually do.

Guide · 15 min readDuchenne Into Adulthood: Transition and Adult Care in AustraliaMedian survival rose from 18.2 to 24 years and the adult services were never built. What changes at 18, what to arrange from 15, and the two-page document that prevents the most harm.

Guide · 14 min readBecker, Limb-Girdle and FSHD Muscular Dystrophy ExplainedThe adult types nobody writes about. Why cardiac risk in Becker ignores how well somebody walks, why your LGMD subtype is the most useful thing you can know, and how adults get diagnosed.

Guide · 15 min readMyotonic Dystrophy: An Australian Guide to DM1 and DM2The most common adult form is a multisystem condition causing cataracts, diabetes and fatal arrhythmias. Why the annual ECG matters most, and the anaesthetic card everyone should carry.

The organs that decide the outcome

The heart, the diaphragm and the bones

In most muscular dystrophies what shortens life is not limb weakness. It is cardiac and respiratory involvement, both of which are now monitored and treated before they cause symptoms.

Guide · 14 min readThe Heart and Muscular Dystrophy: Surveillance and TreatmentCardiac involvement does not track limb weakness, which is the most dangerous assumption in the field. The schedule by type, why an echo alone is not enough, and the carriers nobody follows up.

Guide · 15 min readBreathing and Muscular Dystrophy: Ventilation and Cough AssistFVC under 50 per cent. Peak cough flow under 270 L/min. The specific numbers that should trigger cough assist and ventilation, why night-time comes first, and the oxygen warning.

Guide · 14 min readCorticosteroids, Bone Health and Scoliosis in Muscular DystrophySteroid-treated boys fracture long bones at around 2.6 times the rate, and up to 30 per cent get vertebral fractures that are frequently silent. Why it is still worth it, and the adrenal risk nobody mentions.

Funding, equipment and housing

The things with twelve-month lead times

Custom equipment takes four to eight months and bathrooms take a year, which means a specification written for today is wrong when it arrives.

Guide · 15 min readMuscular Dystrophy and the NDIS: Access and PlanningDuchenne and Becker are named on List B. How to evidence a condition that changes slowly, why paediatric plans do not convert, and the three funding streams almost nobody combines.

Guide · 14 min readEquipment and Home Modifications With Muscular DystrophySpecify for twelve months out. What a powered wheelchair must include, why seating is a respiratory and swallowing issue, and the cheap things worth buying this week without asking anyone.

Guide · 15 min readSupported Independent Living With Muscular DystrophyThe default assumption is that an adult lives with their parents indefinitely. What the alternatives are, the $188,000 overnight question, and the hospital bag that protects the arrangement.

Families and support

Genetics, relatives and the people doing the work

Counselling was documented for only 37 per cent of at-risk second-degree relatives in an Australian study, and carrier women need cardiac surveillance almost none of them receive.

Guide · 14 min readMuscular Dystrophy Genetics, Carriers and Family TestingInheritance by type, what carrier status actually means, the family letter that closes the information gap, reproductive options, and the school conversations worth having early.

Guide · 14 min readSupporting Someone With Muscular Dystrophy: A Support Worker GuideSensation is intact, cognition is usually unaffected, never pull on an arm, and the steroid card is not paperwork. What to escalate the same day, and why this is about energy rather than strength.

If you read nothing else here

Three things that change outcomes

Two threads run through every guide in this library. The first is that the surveillance is the treatment — the organs that fail in muscular dystrophy are monitored and medicated before they cause symptoms, and the schedules exist as specific numbers rather than vague intentions. The second is that in paediatric care the schedule gets delivered because a clinic books it, and in adult care it happens only if somebody asks. Knowing what is due, and asking, is most of the difference.

If a child is walking late, falling, struggling with stairs or has unusually large calves, ask for a creatine kinase blood test. It costs almost nothing, any GP can order it, and in Duchenne it comes back ten to a hundred times normal — which is what closes the three-year gap between Australian parents raising concerns at 1.8 years and diagnosis arriving at 4.8. If the diagnosis is any muscular dystrophy, get the specific subtype and genetic variant in writing, because the cardiac and respiratory protocols differ entirely between them and “muscular dystrophy” alone does not tell a clinician what to monitor. And contact your state muscular dystrophy organisation — the national peak body is Muscular Dystrophy Foundation Australia, whose state and territory members include registered NDIS providers and run equipment programmes, peer support and advocacy. It is consistently the least-used resource in this field. Genetic counselling is free through state genetic services, for the whole family.